AIRLINK 67.70 Increased By ▲ 2.50 (3.83%)
BOP 5.45 Decreased By ▼ -0.12 (-2.15%)
CNERGY 4.48 Decreased By ▼ -0.08 (-1.75%)
DFML 25.71 Increased By ▲ 1.19 (4.85%)
DGKC 68.75 Decreased By ▼ -1.21 (-1.73%)
FCCL 19.93 Decreased By ▼ -0.37 (-1.82%)
FFBL 30.30 Increased By ▲ 1.19 (4.09%)
FFL 9.89 Increased By ▲ 0.06 (0.61%)
GGL 10.03 Increased By ▲ 0.02 (0.2%)
HBL 114.01 Decreased By ▼ -0.24 (-0.21%)
HUBC 130.25 Increased By ▲ 1.15 (0.89%)
HUMNL 6.70 Decreased By ▼ -0.01 (-0.15%)
KEL 4.41 Decreased By ▼ -0.03 (-0.68%)
KOSM 4.80 Decreased By ▼ -0.09 (-1.84%)
MLCF 36.40 Decreased By ▼ -0.60 (-1.62%)
OGDC 132.00 Decreased By ▼ -0.30 (-0.23%)
PAEL 22.45 Decreased By ▼ -0.09 (-0.4%)
PIAA 25.65 Decreased By ▼ -0.24 (-0.93%)
PIBTL 6.64 Increased By ▲ 0.04 (0.61%)
PPL 112.72 Decreased By ▼ -0.13 (-0.12%)
PRL 29.05 Decreased By ▼ -0.36 (-1.22%)
PTC 14.87 Decreased By ▼ -0.37 (-2.43%)
SEARL 57.60 Increased By ▲ 0.57 (1%)
SNGP 66.14 Decreased By ▼ -0.31 (-0.47%)
SSGC 10.97 Decreased By ▼ -0.01 (-0.09%)
TELE 9.00 Increased By ▲ 0.20 (2.27%)
TPLP 11.60 Decreased By ▼ -0.10 (-0.85%)
TRG 68.26 Decreased By ▼ -0.36 (-0.52%)
UNITY 23.50 Increased By ▲ 0.10 (0.43%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 7,335 Increased By 40.4 (0.55%)
BR30 23,902 Increased By 47.4 (0.2%)
KSE100 70,541 Increased By 251.1 (0.36%)
KSE30 23,224 Increased By 53 (0.23%)
Markets

S&P 500, Nasdaq end at record highs on vaccine optimism

  • Pfizer-BioNTech seek EU emergency approval for COVID-19 vaccine.
  • China's November factory activity growth hits decade high.
  • Bipartisan lawmakers propose $908 bln COVID-19 relief bill.
Published December 2, 2020

The S&P 500 and Nasdaq Composite indexes closed at record highs on Tuesday, with investors betting a COVID-19 vaccine will be available soon, and more confident about a speedy economic recovery following upbeat Chinese factory data.

Investors stayed focused on updates about a handful of vaccine candidates and the start of global shipments as drugmakers submit paperwork for regulatory approvals.

Pfizer Inc jumped almost 3% after the drugmaker and Germany's BioNTech SE sought emergency approval of their vaccine candidate from the European regulator.

The partners are neck-and-neck with rival Moderna Inc , which also applied for emergency approval from the European regulator. Its stock tumbled nearly 8% from a record high the day before.

"There is this optimism about what it means as we see news around vaccines emerge," said Bill Northey, senior investment director at US Bank Wealth Management in Minneapolis.

"As we look toward a health solution, we could be sitting on a coiled spring of economic activity, but it could take a while for it to be unleashed."

Earlier in the day, global equities got a boost from data that showed China's factory activity in November increased at its fastest pace in a decade. Several other countries also reported sharp upticks in factory activity.

US data showed a recovery in manufacturing activity lost momentum in November.

All 11 S&P 500 sector indexes rose, with communication services up 2% and leading gains.

Investors also focused on remarks by US Treasury Secretary Steve Mnuchin and Federal Reserve Chair Jerome Powell at the Senate Banking Committee, where they agreed on the need for more aid for small businesses.

Meanwhile, a bipartisan group of US lawmakers unveiled a $908 billion COVID-19 relief bill aimed at breaking a months-long deadlock between Democrats and Republicans over new emergency assistance for small businesses, unemployed people, airlines and other industries during the pandemic.

The Dow Jones Industrial Average rose 0.63% to end at 29,823.92 points, while the S&P 500 gained 1.13% at 3,662.44.

The Nasdaq Composite climbed 1.28% to 12,355.11.

All three main stock indexes gained more than 10% in November.

Zoom Video Communications Inc slumped 15% after warning its gross margins would remain under pressure going into 2021.

Tesla Inc rose 3% after S&P Dow Jones Indices said it would add one of Wall Street's most valuable companies to the S&P 500 index in one go on Dec. 21, rather than in two tranches.

Micron Technology Inc advanced 4.7% as the chipmaker increased its revenue, gross margin and earnings forecast for the first quarter.

Advancing issues outnumbered decliners on the NYSE by a 2.45-to-1 ratio; on Nasdaq, a 1.38-to-1 ratio favored advancers.

The S&P 500 posted 48 new 52-week highs and no new lows; the Nasdaq Composite recorded 185 new highs and eight new lows.

Volume on US exchanges was 13.5 billion shares, compared with the 11.5 billion average over the last 20 trading days.

Comments

Comments are closed.